PTPN11 and psoriasis: Interestingly, SHP2 deficiency in myeloid cell lineages (monocytes, mature macrophages, and granulocytes) or the administration of an allosteric inhibitor of SHP2 ameliorated psoriasis‐like disease in mice, suggesting that SHP2 promotes psoriasis progression with cell specificity.